Ironwood Pharmaceuticals (IRWD) Gains from Investment Securities (2009 - 2025)
Ironwood Pharmaceuticals' (IRWD) quarterly Gains from Investment Securities came in at $3000.0 in Q4 2025, up 100.37% year-on-year from $1497.2 in Q4 2024, and up 142.86% quarter-over-quarter from -$7000.0 in Q3 2025.
Ironwood Pharmaceuticals (IRWD) Gains from Investment Securities (2009 - 2025) Analysis & Trends
Ironwood Pharmaceuticals has disclosed Gains from Investment Securities across 17 years of filings, most recently posting $3000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $3000.0, up 100.37% year-over-year; the trailing twelve-month figure through Dec 2025 was -$816000.0 (down 988.0% YoY), and the FY2025 annual result was $9.9 million, up 118.49% from the prior year.
- Gains from Investment Securities came in at $3000.0 for Q4 2025 at Ironwood Pharmaceuticals, up from -$7000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $9.3 million in Q4 2021 to a low of -$5.6 million in Q3 2021.
- The 5-year median for Gains from Investment Securities is -$13000.0 (2023), against an average of $515500.0.
- Across the five-year window, Gains from Investment Securities slumped 25581.25% in 2021 and surged 3342.11% in 2024, its largest moves.
- Ironwood Pharmaceuticals' Gains from Investment Securities stood at $9.3 million in 2021, then sank by 36.23% to $5.9 million in 2022, then slumped by 100.32% to -$19000.0 in 2023, then slumped by 4173.68% to -$812000.0 in 2024, then soared by 100.37% to $3000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $3000.0 (Q4 2025), -$7000.0 (Q3 2025), and -$812000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Ironwood Pharmaceuticals | 546.74 Mn | 326.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Sep 30, 2025 | -7,000.00 |
| Dec 31, 2024 | -812,000.00 |
| Dec 31, 2024 | -812,000.00 |
| Jun 30, 2024 | 121,000.00 |
| Jun 30, 2024 | 121,000.00 |
| Mar 31, 2024 | 616,000.00 |
| Mar 31, 2024 | 616,000.00 |
| Mar 31, 2023 | -19,000.00 |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | 5.93 Mn |
| Dec 31, 2022 | 5.93 Mn |
| Sep 30, 2022 | -151,000.00 |
| Sep 30, 2022 | -151,000.00 |
| Jun 30, 2022 | -747,000.00 |
| Jun 30, 2022 | -747,000.00 |
| Mar 31, 2022 | -417,000.00 |
| Mar 31, 2022 | -417,000.00 |